UnitedHealth Earnings: Rate Actions Improve Medical Cost Ratio and Boost 2026 Outlook

Key Morningstar Metrics for UnitedHealth Group

• : $427.00
• : ★★★★

• Morningstar Economic Moat Rating

  : Narrow

• Morningstar Uncertainty Rating

  : High

What We Thought of UnitedHealth Group’s Earnings

On April 21, UnitedHealth Group UNH reported first-quarter results that included 2% revenue growth and flat adjusted earnings per share. Management also raised its 2026 outlook to adjusted EPS of at least $18.25, from at least $17.75 previously. The shares rallied about 9% in early trading on the news.

Why it matters: Investors appear relieved that guidance is rising already in 2026, rather than the industry norm of falling in 2025. The reason for the increase—an improving medical cost ratio in the beleaguered medical insurance operations—was especially reassuring.

• Management said its MCR improved after repricing at-risk plans across the board for 2026. We were pleased to see the firm making progress in this metric, despite elevated medical utilization trends.
• Optum profits declined as the firm invested primarily in Optum Health (caregiving) and Optum Insight (analytical solutions), but those profit pressures should ease in the second half of the year. Optum Rx (pharmacy benefit management) basically treaded water, including ongoing business model changes to improve transparency.

The bottom line: Recognizing improving margin trends, we have increased our 2026 expectations a bit, but that was not enough to materially adjust our $427 fair value estimate. The shares continue to look moderately undervalued, and we appreciate that the company plans to repurchase some undervalued stock.

• While this guidance increase follows the early April increase in the 2027 Medicare Advantage rate, we continue to see elevated operational and regulatory risk at UnitedHealth. This is reflected in our High Uncertainty rating, which is about one notch higher than usual.
• However, our Narrow Economic Moat Rating is intact at this top-tier managed care organization. The firm appears to have significant room for operational challenges or regulatory changes before its long-term ability to generate economic profits would be impaired.